BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 30565579)

  • 1. [Management of nausea and vomiting in cancer patients. Use of transdermal patches containing granisetron in patients affected by head and neck squamous-cell carcinoma].
    Rondonotti D; Gennari A
    Recenti Prog Med; 2018 Nov; 109(11):3e-5e. PubMed ID: 30565579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transdermal granisetron: a guide to its use in preventing nausea and vomiting induced by chemotherapy.
    Keating GM; Duggan ST; Curran MP
    CNS Drugs; 2012 Sep; 26(9):787-90. PubMed ID: 22834568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granisetron transdermal system: a new option to help prevent chemotherapy-induced nausea and vomiting.
    Schulmeister L
    Clin J Oncol Nurs; 2009 Dec; 13(6):711-4. PubMed ID: 19948469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Out-patient management of nausea and vomiting in multiday therapy of acute myeloid leukemia in the elderly. Use of granisetron in slow-release transdermal formulation. Clinical case].
    Piccioni AL
    Recenti Prog Med; 2019 Mar; 110(3):10e-13e. PubMed ID: 30968859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of chemotherapy-induced nausea and vomiting in patients receiving multiple-day highly or moderately emetogenic chemotherapy: role of transdermal granisetron.
    Coluzzi F; Mattia C
    Future Oncol; 2016 Aug; 12(16):1865-76. PubMed ID: 27184113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transdermal versus oral granisetron in controlling chemotherapy-induced nausea and vomiting: a meta-analysis.
    Chua AV; Hernandez ARB; Real IO
    Support Care Cancer; 2020 Dec; 28(12):5611-5619. PubMed ID: 32623521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of a granisetron transdermal system for the treatment of chemotherapy-induced nausea and vomiting.
    Howell J; Smeets J; Drenth HJ; Gill D
    J Oncol Pharm Pract; 2009 Dec; 15(4):223-31. PubMed ID: 19304880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiemetic efficacy of an oral suspension of granisetron plus dexamethasone and influence of quality of life on risk for nausea and vomiting.
    Jordan K; Grothey A; Kegel T; Fibich C; Schöbert C
    Onkologie; 2005 Feb; 28(2):88-92. PubMed ID: 15662112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy of granisetron for cancer patients undergoing platinum-based chemotherapy: comparison of 1 miligram versus 3 miligram doses in preventing nausea and vomiting.
    Kurnianda J; Hisyam B; Wahyuningsih E; Hutajulu SH
    Acta Med Indones; 2005; 37(4):210-3. PubMed ID: 16317218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transdermal granisetron for the prevention of nausea and vomiting following moderately or highly emetogenic chemotherapy in Chinese patients: a randomized, double-blind, phase III study.
    Yang LQ; Sun XC; Qin SK; Chen YX; Zhang HL; Cheng Y; Chen ZD; Shi JH; Wu Q; Bai YX; Han BH; Liu W; Ouyang XN; Liu JW; Zhang ZH; Li YQ; Xu JM; Yu SY
    Chin Clin Oncol; 2016 Dec; 5(6):79. PubMed ID: 28061543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A nurse-led multidomain intervention to improve the management of chemotherapy-induced nausea and vomiting in patients with head and neck cancers: A randomized controlled trial.
    Cao J; Chen C; Wang Y; Liu M; Han X; Li H
    Eur J Oncol Nurs; 2024 Jun; 70():102615. PubMed ID: 38797114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Manifest Anxiety Scale for evaluation of effects of granisetron in chemotherapy with CDDP and 5FU for head and neck cancer.
    Fujii M; Ohno Y; Tokumaru Y; Imanishi Y; Kanke M; Tomita T; Kanzaki J
    Support Care Cancer; 2001 Jul; 9(5):366-71. PubMed ID: 11497391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of oral granisetron versus oral prochlorperazine in preventing nausea and emesis in patients receiving moderately emetogenic chemotherapy.
    Burris H; Hesketh P; Cohn J; Moriconi W; Ryan T; Friedman C; Fitts D
    Cancer J Sci Am; 1996; 2(2):85-90. PubMed ID: 9166505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of granisetron alone and granisetron plus hydroxyzine hydrochloride for prophylactic treatment of emesis induced by cisplatin chemotherapy.
    Tsukuda M; Furukawa S; Kokatsu T; Enomoto H; Kubota A; Furukawa M
    Eur J Cancer; 1995 Sep; 31A(10):1647-9. PubMed ID: 7488417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of effects between single vs five-day injection of granisetron for combination chemotherapy with cisplatin and 5-fluorouracil for head and neck cancer].
    Fujii M; Ohno Y; Tokumaru Y; Imanishi Y; Kanke M; Kanzaki J
    Gan To Kagaku Ryoho; 1997 Jul; 24(9):1095-101. PubMed ID: 9239162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of granisetron, ondansetron, and tropisetron in the prophylaxis of acute nausea and vomiting induced by cisplatin for the treatment of head and neck cancer: a randomized controlled trial.
    Mantovani G; Macciò A; Bianchi A; Curreli L; Ghiani M; Proto E; Santona MC
    Cancer; 1996 Mar; 77(5):941-8. PubMed ID: 8608488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A granisetron patch (sancuso).
    Med Lett Drugs Ther; 2008 Dec 15-29; 50(1301-1302):103-4; quiz p 2 following 104. PubMed ID: 19078867
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of single-dose oral granisetron versus intravenous ondansetron in the prevention of nausea and vomiting induced by moderately emetogenic chemotherapy: a multicenter, double-blind, randomized parallel study.
    Perez EA; Hesketh P; Sandbach J; Reeves J; Chawla S; Markman M; Hainsworth J; Bushnell W; Friedman C
    J Clin Oncol; 1998 Feb; 16(2):754-60. PubMed ID: 9469367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the efficacy and safety of oral granisetron plus dexamethasone with intravenous ondansetron plus dexamethasone to control nausea and vomiting induced by moderate/severe emetogenic chemotherapy.
    Chiou TJ; Tzeng WF; Wang WS; Yen CC; Fan FS; Liu JH; Chen PM
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Oct; 63(10):729-36. PubMed ID: 11076429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapeutic potential of Granisetron (Kitryl) for the prevention of nausea and vomiting induced by cytostatic drugs].
    Gershanovich ML; Beresneva IA
    Vopr Onkol; 1998; 44(2):225-8. PubMed ID: 9615833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.